KR830001295A - 세파로스포린 유도체의 제조법 - Google Patents

세파로스포린 유도체의 제조법 Download PDF

Info

Publication number
KR830001295A
KR830001295A KR1019790004155A KR790004155A KR830001295A KR 830001295 A KR830001295 A KR 830001295A KR 1019790004155 A KR1019790004155 A KR 1019790004155A KR 790004155 A KR790004155 A KR 790004155A KR 830001295 A KR830001295 A KR 830001295A
Authority
KR
South Korea
Prior art keywords
preparation
sepharosporin
derivatives
aminothiazol
tetrazol
Prior art date
Application number
KR1019790004155A
Other languages
English (en)
Other versions
KR880000181B1 (ko
Inventor
히데아끼 나쓰가리
이와오 미가미
미찌히꼬 오찌아이
Original Assignee
다쓰오까 스에오
다께다야꾸 힝고오 교가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다쓰오까 스에오, 다께다야꾸 힝고오 교가부시끼가이샤 filed Critical 다쓰오까 스에오
Priority to KR7904155A priority Critical patent/KR880000181B1/ko
Publication of KR830001295A publication Critical patent/KR830001295A/ko
Priority to KR1019850002935A priority patent/KR890000787B1/ko
Application granted granted Critical
Publication of KR880000181B1 publication Critical patent/KR880000181B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

내용 없음

Description

세파로스포린 유도체의 제조법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 실시예 1에서 얻은 분말 X선회석도(CuKa. 40KV. 45mA)를, 제2도는 실시예 1에서 얻은 목적물의 적외선 흡수스펙틀(KBr)을 나타냄.

Claims (1)

  1. 7β-[2-(2-아미노티아졸-4-일)-(Z)-2-메톡시이미노아세타미드]-3-[(1-메틸-1H-테트라졸-5-일)티오메틸]세프]-3-엠-4-카르본산과 HCl 또는 HBr과를 반응시키는 것을 특징으로 하는 7β-[2-(2-아미노티아졸-4-일)-(Z)-2-메톡시이미노아세타미드]-3-[(1-메틸-1H-테트라졸-5-일티오메틸]세프-3-엠-4-카르본산 1분자와 HCl 또는 HBr2분의 1분자와의 결정성염의 제조법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR7904155A 1979-11-27 1979-11-27 세팔로스포린 유도체의 결정성염의 제조방법 KR880000181B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR7904155A KR880000181B1 (ko) 1979-11-27 1979-11-27 세팔로스포린 유도체의 결정성염의 제조방법
KR1019850002935A KR890000787B1 (ko) 1979-11-27 1985-04-30 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7904155A KR880000181B1 (ko) 1979-11-27 1979-11-27 세팔로스포린 유도체의 결정성염의 제조방법

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1019850002935A Division KR890000787B1 (ko) 1979-11-27 1985-04-30 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법
KR1019850002934A Division KR850007927A (ko) 1985-04-30 1985-04-30 세팔로스포린 유도체 결정성염의 제조방법

Publications (2)

Publication Number Publication Date
KR830001295A true KR830001295A (ko) 1983-04-30
KR880000181B1 KR880000181B1 (ko) 1988-03-12

Family

ID=19213669

Family Applications (2)

Application Number Title Priority Date Filing Date
KR7904155A KR880000181B1 (ko) 1979-11-27 1979-11-27 세팔로스포린 유도체의 결정성염의 제조방법
KR1019850002935A KR890000787B1 (ko) 1979-11-27 1985-04-30 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019850002935A KR890000787B1 (ko) 1979-11-27 1985-04-30 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법

Country Status (1)

Country Link
KR (2) KR880000181B1 (ko)

Also Published As

Publication number Publication date
KR850007928A (ko) 1985-12-11
KR890000787B1 (ko) 1989-04-07
KR880000181B1 (ko) 1988-03-12

Similar Documents

Publication Publication Date Title
PT66353B (fr) Procede de preparation de nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique
PT67815A (fr) Procede de preparation de nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-aminothiazolyl acetamido cephalosporanique
KR830004317A (ko) 세팔로스포린 항생제 또는 개선점
PT66099B (fr) Procede de preparation de nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique
KR830000246A (ko) 세팔로스포린 항생제의 개발
LU79313A1 (fr) Procede de preparation de nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique
JPS6479188A (en) 3,7-disubstituted-2-or 3-cephem-4-carboxylic acid compound or intermediate for salts thereof
NL7511490A (nl) Werkwijze voor de bereiding van nieuwe 2,6-dige- substitueerde 2-fenyliminoimidazolidinen en zuur- additiezouten daarvan.
FI792206A (fi) Foerfarande foer framstaellning av nya oxadiazolopyrimidinderivat
KR830001295A (ko) 세파로스포린 유도체의 제조법
CH612427A5 (en) Process for the preparation of heterocyclic compounds substituted by acylamino groups
KR840008372A (ko) 무수결정성 셒타지딤의 제조방법
KR830005235A (ko) 결정성염의 제조방법
PT66944B (fr) Procede de preparation de nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique
NL7412801A (nl) Werkwijze ter bereiding van 5-gesubstitueerde alkyl-1,3,4-thiadiazool-2-thiolverbindingen uten daarvan.
LU79080A1 (fr) Procede de preparation de nouvelles oximes derivees de 1'acide 3-thiadiazolyl thiomethyl 7-amino thiazolyl acetamido cephalosporanique
GB1525626A (en) Tetrazolethiomethyl cephalosporin compounds
ES8100299A1 (es) Un procedimiento para preparar un semi-acido-sal cristalino de un derivado de cefalosporina
OA06223A (fr) Procédé de préparation de nouvelles oximes dérivées de l'acide 3-azidométhyl 7-amino thiazolyl acétamido céphalosporanique.
KR850007927A (ko) 세팔로스포린 유도체 결정성염의 제조방법
OA05542A (fr) Procédé de préparation de nouvelles oximes dérivées de l'acide 7-amino thiazolyl acétamido céphalosporanique.
IE44614L (en) Heterocyclylcarbonylpiperazinylquinazolines
SE7702736L (sv) Forfarande for framstellning av 7-alkoxi- eller 7-aralkoxi-3-klormetylcefemer
FR2275532A1 (fr) Procede de preparation de composes de 4-halo-4', 4'' - diarylamino - triphenyl-methanes symetriques
SE7702797L (sv) Forfarande for framstellning av 5-fluorouracilderivat